Related Experiment Video
Updated: Jan 19, 2026
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Effect of Imipramine on radiosensitivity of Prostate Cancer: An In Vitro Study
Songul Barlaz Us1, Fatma Sogut2, Metin Yildirim3
1Department of Radiation Oncology Mersin-Turkey, School of Medicine, Mersin University , Mersin , Turkey.
Abstract:
Prostate cancer is the most common cancer and leading cause of cancer death for males. Imipramine (IMI), which is a tricyclic antidepressant, has also been shown to has antineoplastic effect. This study was performed to investigate the radiosensitizing effect of IMI on DU145 prostate cancer cell. Cells were divided into 4 groups. Cell index, apoptotic activity, cell cycle arrest, oxidative stress and EAG1 channel currents were determined in all groups. Our findings showed that combined treatment with IMI and radiotherapy (RAD) did not enhance radiosensitivity of DU145 cells but as unexpected finding, treatment of IMI alone was more effective in DU145 cells.
Related Concept Videos
09:45Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
07:16Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
05:07Intra-prostatic Injection of Cancer Cells: A Technique to Deliver Cancer Cells for Establishing Orthotopic Prostate Cancer Mouse Model
06:48An Orthotopic Murine Model of Human Prostate Cancer Metastasis
08:54Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
04:33Generating Chemoresistant Prostate Cancer Cells: A Procedure for Obtaining Drug-resistant Cancer Cells In Vitro